Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Plus Therapeutics Inc
(NQ:
PSTV
)
1.750
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
75,438
Open
1.730
Bid (Size)
1.730 (3)
Ask (Size)
1.770 (4)
Prev. Close
1.750
Today's Range
1.685 - 1.801
52wk Range
0.9694 - 3.210
Shares Outstanding
2,879,620
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PSTV Stock Earnings: Plus Therapeutics Beats EPS, Misses Revenue for Q1 2024
May 15, 2024
PSTV stock results show that Plus Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense
April 22, 2024
Plus Therapeutics will secure $3 million in funding from the Department of Defense for pediatric brain cancer trial expansion.
Via
Benzinga
Performance
YTD
-5.41%
-5.41%
1 Month
+9.37%
+9.37%
3 Month
+5.42%
+5.42%
6 Month
-21.52%
-21.52%
1 Year
-17.84%
-17.84%
More News
Read More
PSTV Stock Earnings: Plus Therapeutics Beats EPS, Beats Revenue for Q4 2023
March 05, 2024
Via
InvestorPlace
Recap: Plus Therapeutics Q4 Earnings
March 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 20, 2023
Via
Benzinga
Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2
November 09, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Plus Therapeutics Stock Popped Today
November 01, 2023
Via
Benzinga
Earnings Outlook For Plus Therapeutics
October 30, 2023
Via
Benzinga
Earnings Scheduled For March 5, 2024
March 05, 2024
Via
Benzinga
Plus Therapeutics Earnings Preview
March 04, 2024
Via
Benzinga
Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 01, 2023
Via
Benzinga
Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
November 01, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 01, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 31, 2023
Via
Benzinga
Why Is Liquid Biopsy Firm Biocept Stock Trading Lower Today?
October 16, 2023
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
12 Health Care Stocks Moving In Friday's After-Market Session
September 29, 2023
Via
Benzinga
Earnings Scheduled For October 31, 2023
October 31, 2023
Via
Benzinga
Plus Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
September 18, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 08, 2023
Via
Benzinga
Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today?
September 08, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 08, 2023
Via
InvestorPlace
EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers
September 08, 2023
Via
Benzinga
Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference
August 14, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
